CME Group Inc(CME) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 23.3 | EPS (ttm) | 11.79 | Insider Own | 1.38% | Shs Outstand | 359.3M | Perf Week | -4.09% |
| Market Cap | 98.79B | Forward P/E | 21.28 | EPS next Y | 5.37% | Insider Trans | -0.97% | Shs Float | 354.6M | Perf Month | 4.21% |
| Enterprise Value | 100.38B | PEG | 2.9 | EPS next Q | 2.94 | Inst Own | 91.47% | Short Float | 1.47% | Perf Quarter | 7.35% |
| Income | 4.27B | P/S | 14.59 | EPS this Y | 9.4% | Inst Trans | -1.75% | Short Ratio | 1.83 | Perf Half Y | -10.32% |
| Sales | 6.77B | P/B | 3.72 | EPS next 5Y | 7.33% | ROA | 2.29% | Short Interest | 5.20M | Perf YTD | 2.59% |
| Book/sh | 73.82 | P/C | 43.33 | EPS past 3/5Y | 14.69% 13.7% | ROE | 15.8% | 52W High | -14.89% ($322.82) | Perf Year | 7.12% |
| Cash/sh | 6.34 | P/FCF | 23.45 | Sales past 3/5Y | 9.11% 5.95% | ROIC | 14.13% | 52W Low | 25.85% ($218.31) | Perf 3Y | 43.56% |
| Dividend Est. | $11.51 (4.19%) | EV/EBITDA | 21.17 | EPS Y/Y TTM | 14.78% | Gross Margin | 82.65% | Volatility(W/M) | 2.09% 2.08% | Perf 5Y | 59.25% |
| Dividend TTM | 5.13 | EV/Sales | 14.82 | Sales Y/Y TTM | 5.1% | Oper. Margin | 65.1% | ATR (14) | 5.86 | Perf 10Y | 215.29% |
| Dividend Ex-Date | 2026/9/9 | Quick Ratio | 1.02 | EPS Q/Q | 2.66% | Profit Margin | 63.11% | RSI (14) | 52.02 | Recom | 2.47 |
| Dividend Gr. 3/5Y | -16.21% -3.26% | Current Ratio | 1.02 | Sales Q/Q | 0.84% | SMA20 | -0.49% ($276.09) | Beta | 0.24 | Target Price | $283.87 |
| Payout | 44.8% | Debt/Eq | 0.15 | Earnings | 2026/7/22 | SMA50 | 5.38% ($260.71) | Rel Volume | 0.56 | Prev Close | $278.23 |
| Employees | 3875 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 2.92% 1.43% | SMA200 | -0.74% ($276.79) | Avg Volume(3M) | 2.84M | Price | $274.74 |
| IPO | 2002/12/6 | Option/Short | Yes/Yes | Trades | 34380 | Volume | 1,599,582 | Change | -1.25% |
Company
CME is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
📈 A global exchange group operating derivatives and futures exchanges. Headquartered in Chicago, Illinois, USA, with roots dating back to 1898, the group has been trading and clearing interest rate, currency, equity index, energy, agricultural, and metal derivatives globally.
Over the past 1 year, roughly in the middle
15% below its 1-year high.
CME makes money exceptionally well
65.1% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +9.4% this year.
Tap to view numbers
But it is not cheap
Trading at 23.3 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +43.6% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 4.19% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 91.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HULL 0.05%
FDIQ 0.04%
DIVO 0.04%
IAI 0.04%
GENZ 0.04%It ranks #2 in the industry
Based on market cap of $99B.
CME $99B PER 23.3
SPGI $123B PER 25.5
ICE $88B PER 22.1
MCO $82B PER 30.1
FAQ
What kind of company is CME?
CME belongs to the Financial sector and operates in the Financial Data & Stock Exchanges industry.
What is the market cap of CME?
The market cap of CME is approximately $98.8B, ranking 170 within its sector.
Does CME pay dividends?
CME has a dividend yield of approximately 4.19%, with an annual dividend of $11.51.
What is the P/E ratio of CME?
CME has a P/E ratio of approximately 23.3x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for CME?
CME has recorded a 52-week high of $322.82 and a low of $218.31.
